Advertisement

Topics

Abivax SA ABVX Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

09:04 EDT 24 Aug 2017 | BioPortfolio Report Blog

Summary

Abivax SA Abivax is a biotechnology company that researches, develops and commercializes antiviral therapies and therapeutic vaccines for the treatment of infectious diseases. Its pipeline product portfolio includes ABX464, a small molecule against HIV; ABX311 for chikungunya; ABX544 to treat EBOLA virus infection; and ABX196, an immune enhancer candidate for vaccination. The company leverages three technology platforms for drug discovery: antiviral, immune enhancing and polyclonal antibodies. It has collaborations with Centro de Ingenieria Genetica y Biotecnologia CIGB, the CNRS, Scripps Research Institute, BC Cancer Agency, the University of Chicago and the Institut Pasteur, among others. Abivax is headquartered in Paris, France.

Abivax SA Key Recent Developments

Apr 11,2017: ABIVAX expands its antiviral portfolio with compounds targeting Zika virus
Mar 15,2017: ABIVAX Announces 2016 FullYear Results and Progress Report
Feb 23,2017: ABIVAX Has Discovered Novel Antiviral Molecules with Potential for Dengue Virus Treatment
Jan 09,2017: ABIVAX to receive 8.4 million from Bpifrance Invest in the Future Program PIA for the development of innovative antiviral drugs
Dec 15,2016: ABIVAX appoints Didier Blondel as Chief Financial Officer

This comprehensive SWOT profile of Abivax SA provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Abivax SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*, x000D
x000D
Business description A detailed description of the company's operations and business divisions.x000D
Corporate strategy Analyst's summarization of the company's business strategy.x000D
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.x000D
Company history Progression of key events associated with the company.x000D
Major products and services A list of major products, services and brands of the company.x000D
Key competitors A list of key competitors to the company.x000D
Key employees A list of the key executives of the company.x000D
Executive biographies A brief summary of the executives' employment history.x000D
Key operational heads A list of personnel heading key departments/functions.x000D
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.x000D
Key manufacturing facilities A list of key manufacturing facilities of the company.x000D
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.x000D
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.x000D
x000D
Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,x000D
x000D
You get detailed information about the company and its operations to identify potential customers and suppliers.x000D
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.x000D
x000D
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.x000D
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. x000D
x000D
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.x000D
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.x000D
x000D
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.x000D
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.x000D
x000D
Gain key insights into the company for academic or business research.x000D
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Abivax SA ABVX Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "Abivax SA ABVX Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...